Carlos E. Santos net worth and biography

Carlos Santos Biography and Net Worth

CFO of Legend Biotech

Carlos Santos joined Legend Biotech in August 2025 as our Chief Financial Officer.

Mr. Santos is a seasoned finance executive with over 20 years of experience leading financial operations in the pharmaceutical and technology sectors across the United States, Latin America, Europe, the Middle East, and Africa.

Prior to joining Legend, Mr. Santos was CFO for US Oncology at AstraZeneca. During his decade-long tenure there, he also served as the Acting Area Vice President for Latin America (LATAM) and the Area CFO for LATAM. He also spent 6 years at Alcon, a division of Novartis, where he held CFO roles for European markets and Brazil. For nearly a decade, Mr. Santos held financial leadership positions at Intel Corporation in Europe and Latin America.

Mr. Santos earned his MBA in Corporate Finance from the University of Bristol in the United Kingdom.

What is Carlos E. Santos' net worth?: The estimated net worth of Carlos E. Santos is at least $262.84 thousand as of September 21st, 2026. Mr. Santos owns 14,246 shares of Legend Biotech stock worth more than $262,839 as of September 24th. This net worth estimate does not reflect any other investments that Mr. Santos may own. Learn More about Carlos E. Santos' net worth.
How do I contact Carlos E. Santos?: The corporate mailing address for Mr. Santos and other Legend Biotech executives is 2101 COTTONTAIL LANE, SOMERSET NJ, 08873. Legend Biotech can also be reached via phone at 732-317-5050 and via email at [email protected]. Learn More on Carlos E. Santos' contact information.
Has Carlos E. Santos been buying or selling shares of Legend Biotech?: During the last ninety days, Carlos E. Santos has sold $49,630.20 of Legend Biotech stock. Most recently, Carlos E. Santos sold 5,430 shares of the business's stock in a transaction on Monday, September 21st. The shares were sold at an average price of $9.14, for a transaction totalling $49,630.20. Following the completion of the sale, the chief financial officer now directly owns 14,246 shares of the company's stock, valued at $130,208.44. Learn More on Carlos E. Santos' trading history.
Who are Legend Biotech's active insiders?: Legend Biotech's insider roster includes Ying Huang (CEO), and Carlos Santos (CFO). Learn More on Legend Biotech's active insiders.
Are insiders buying or selling shares of Legend Biotech?: During the last year, insiders at the sold shares 3 times. They sold a total of 20,932 shares worth more than $219,034.40. The most recent insider tranaction occured on September, 21st when CFO Carlos E. Santos sold 5,430 shares worth more than $49,630.20. Insiders at Legend Biotech own 0.0% of the company. Learn More about insider trades at Legend Biotech.
Information on this page was last updated on 9/21/2026.

Carlos E. Santos Insider Trading History at Legend Biotech

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/21/2026	Sell	5,430	$9.14	$49,630.20	14,246

Carlos E. Santos Buying and Selling Activity at Legend Biotech

Legend Biotech Company Overview

Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. The company was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation.

Today's Range

Now: $18.45

$18.28

$19.08

50 Day Range

MA: $20.38

$17.00

$23.54

2 Week Range

Now: $18.45

$16.24

$37.50

Volume

2,408,693 shs

Average Volume

1,991,488 shs

Market Capitalization

$3.58 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.4